Literature DB >> 19223688

Association between omega-3 fatty acids and depressive symptoms among patients with established coronary artery disease: data from the Heart and Soul Study.

Sadia Ali, Sachin K Garg, Beth E Cohen, Prashant Bhave, William S Harris, Mary A Whooley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19223688      PMCID： PMC2755049          DOI： 10.1159/000203118

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN： 0033-3190            Impact factor:   17.659


× No keyword cloud information.
  23 in total

1.  Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group.

Authors:  A A Ariyo; M Haan; C M Tangen; J C Rutledge; M Cushman; A Dobs; C D Furberg
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

Review 2.  Depression and heart disease.

Authors:  François Lespérance; Nancy Frasure-Smith
Journal:  Cleve Clin J Med       Date:  2007-02       Impact factor: 2.321

3.  Depression and cardiovascular disease: healing the broken-hearted.

Authors:  Mary A Whooley
Journal:  JAMA       Date:  2006-06-28       Impact factor: 56.272

4.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

Review 5.  Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique.

Authors:  Jessica Sontrop; M Karen Campbell
Journal:  Prev Med       Date:  2005-12-07       Impact factor: 4.018

6.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

7.  Depression and risk of heart failure among older persons with isolated systolic hypertension.

Authors:  J Abramson; A Berger; H M Krumholz; V Vaccarino
Journal:  Arch Intern Med       Date:  2001-07-23

8.  Relation of low socioeconomic status to C-reactive protein in patients with coronary heart disease (from the heart and soul study).

Authors:  Lindsey A Lubbock; Anne Goh; Sadia Ali; James Ritchie; Mary A Whooley
Journal:  Am J Cardiol       Date:  2005-10-11       Impact factor: 2.778

9.  Low levels of docosahexaenoic acid identified in acute coronary syndrome patients with depression.

Authors:  Gordon B Parker; Gabriella A Heruc; Therese M Hilton; Amanda Olley; Heather Brotchie; Dusan Hadzi-Pavlovic; Cheryl Friend; Warren F Walsh; Roland Stocker
Journal:  Psychiatry Res       Date:  2006-02-24       Impact factor: 3.222

10.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

Authors:  Mitsuhiro Yokoyama; Hideki Origasa; Masunori Matsuzaki; Yuji Matsuzawa; Yasushi Saito; Yuichi Ishikawa; Shinichi Oikawa; Jun Sasaki; Hitoshi Hishida; Hiroshige Itakura; Toru Kita; Akira Kitabatake; Noriaki Nakaya; Toshiie Sakata; Kazuyuki Shimada; Kunio Shirato
Journal:  Lancet       Date:  2007-03-31       Impact factor: 79.321
View more
  8 in total

1.  Omega-3 fatty acid biomarkers and subsequent depressive symptoms.

Authors:  Jane E Persons; Jennifer G Robinson; Eric M Ammann; William H Coryell; Mark A Espeland; William S Harris; JoAnn E Manson; Jess G Fiedorowicz
Journal:  Int J Geriatr Psychiatry       Date:  2013-12-11       Impact factor: 3.485

Review 2.  The impact of depression in heart disease.

Authors:  Yelizaveta Sher; Sermsak Lolak; José R Maldonado
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

3.  Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: insights from the Heart and Soul Study.

Authors:  S Marlene Grenon; Eric Vittinghoff; Christopher D Owens; Michael S Conte; Mary Whooley; Beth E Cohen
Journal:  Vasc Med       Date:  2013-07-08       Impact factor: 3.239

Review 4.  The omega-3 index: clinical utility for therapeutic intervention.

Authors:  William S Harris
Journal:  Curr Cardiol Rep       Date:  2010-11       Impact factor: 2.931

5.  Baseline blood levels of omega-3 and depression remission: a secondary analysis of data from a placebo-controlled trial of omega-3 supplements.

Authors:  Robert M Carney; Brian C Steinmeyer; Kenneth E Freedland; Eugene H Rubin; Michael W Rich; William S Harris
Journal:  J Clin Psychiatry       Date:  2016-02       Impact factor: 4.384

6.  Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease.

Authors:  Mary A Whooley; Peter de Jonge; Eric Vittinghoff; Christian Otte; Rudolf Moos; Robert M Carney; Sadia Ali; Sunaina Dowray; Beeya Na; Mitchell D Feldman; Nelson B Schiller; Warren S Browner
Journal:  JAMA       Date:  2008-11-26       Impact factor: 56.272

7.  Associations between omega fatty acid consumption and depressive symptoms among individuals seeking behavioural weight loss treatment.

Authors:  Anna K Luke; E Whitney Evans; Dale S Bond; J Graham Thomas
Journal:  Obes Sci Pract       Date:  2016-01-15

Review 8.  Importance of EPA and DHA Blood Levels in Brain Structure and Function.

Authors:  Clemens von Schacky
Journal:  Nutrients       Date:  2021-03-25       Impact factor: 5.717
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.